Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 76951-77000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05799001
Dance Workshop for Institutionalized Seniors With Behavioral and Psychological Symptoms of Dementia
NARecruiting
180 participants
Started: Mar 8, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor2 locations
NCT05670496
Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.
N/ARecruiting
600 participants
Started: Mar 8, 2023 · Completed: Dec 1, 2032
2 conditions1 sponsor1 location
NCT05868707
OH2 Injection in Melanoma
PHASE3Recruiting
340 participants
Started: Mar 8, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor30 locations
NCT05673694
To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.
PHASE1Recruiting
70 participants
Started: Mar 8, 2023 · Completed: Jan 2, 2026
1 condition1 sponsor5 locations
NCT05843357
PAPSY - Memory in Psychiatry
N/AActive, not recruiting
1,000 participants
Started: Mar 8, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06108661
Effects of ELDOA and Slump Stretching on Mechanical Low Back Pain
NARecruiting
38 participants
Started: Mar 7, 2023 · Completed: Dec 15, 2023
1 condition1 sponsor1 location
NCT05818943
Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
PHASE1Active, not recruiting
24 participants
Started: Mar 7, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor15 locations
NCT05664516
A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder
PHASE2Recruiting
60 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05662124
ILD: Health Outcomes in Remote Digital Monitoring Versus Usual Care
NAActive, not recruiting
139 participants
Started: Mar 7, 2023 · Completed: Apr 30, 2025
1 condition5 sponsors12 locations
NCT05858242
Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer
N/ARecruiting
100 participants
Started: Mar 7, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05728814
DOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer
N/ARecruiting
100 participants
Started: Mar 7, 2023 · Completed: Sep 12, 2024
1 condition1 sponsor1 location
NCT05742698
Nabilone for Agitation in Frontotemporal Dementia
PHASE2Recruiting
45 participants
Started: Mar 7, 2023 · Completed: May 31, 2026
6 conditions2 sponsors7 locations
NCT06444971
Effects of Post-isometric Relaxation Technique on Chest Expansion and Pulmonary Function Tests in Smokers
NARecruiting
40 participants
Started: Mar 7, 2023 · Completed: Jun 27, 2024
1 condition1 sponsor1 location
NCT05149859
Compuls-BED-Severity
N/ARecruiting
200 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors2 locations
NCT05786716
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
PHASE2/PHASE3Recruiting
30 participants
Started: Mar 7, 2023 · Completed: Oct 31, 2029
11 conditions5 sponsors27 locations
NCT05842551
Prismatic Lenses and tDCS in Neglect
NARecruiting
30 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06511648
Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations
PHASE2Recruiting
90 participants
Started: Mar 7, 2023 · Completed: Mar 31, 2029
1 condition3 sponsors19 locations
NCT05439083
Immunogenicity of 9-valent HPV Vaccine
PHASE4Recruiting
120 participants
Started: Mar 7, 2023 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT04685317
Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation
NARecruiting
48 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05635708
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
400 participants
Started: Mar 7, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor61 locations
NCT06127433
The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes
PHASE4Recruiting
210 participants
Started: Mar 7, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05897710
Virtual World-Based Cardiac Rehabilitation
NAActive, not recruiting
2,881 participants
Started: Mar 7, 2023 · Completed: Sep 1, 2028
3 conditions4 sponsors1 location
NCT05649748
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)
PHASE2/PHASE3Active, not recruiting
91 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor45 locations
NCT05414448
Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection
NARecruiting
1,726 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05677308
LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)
N/AActive, not recruiting
61 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor40 locations
NCT05775094
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
PHASE1Active, not recruiting
10 participants
Started: Mar 7, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor7 locations
NCT05430204
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy
NAActive, not recruiting
816 participants
Started: Mar 7, 2023 · Completed: Jan 1, 2025
1 condition2 sponsors1 location
NCT05905705
Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy
N/ARecruiting
50 participants
Started: Mar 7, 2023 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT04128072
Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
PHASE2Recruiting
43 participants
Started: Mar 7, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor13 locations
NCT05742932
Study Evaluating the Performance and Safety of Global D Implants Indicated for Trauma Surgery (CMF-TRAUMA)
N/ARecruiting
102 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor2 locations
NCT05764759
Investigating Novel Smoking Cessation Primary Care Interventions in Rural Environments
NARecruiting
288 participants
Started: Mar 7, 2023 · Completed: Aug 15, 2027
1 condition2 sponsors1 location
NCT05765825
Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC
PHASE2Recruiting
61 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor8 locations
NCT05707078
PET/CT Follow up for Head and Neck Squamous Cell Carcinoma
NARecruiting
600 participants
Started: Mar 7, 2023 · Completed: Dec 30, 2030
2 conditions1 sponsor1 location
NCT06171529
Efficacy of a Single Injection of CTM for Post-Operative CMC Arthritis
NAEnrolling by invitation
50 participants
Started: Mar 7, 2023 · Completed: Jan 31, 2026
4 conditions2 sponsors1 location
NCT05360095
Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education
NARecruiting
1,125 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2025
5 conditions2 sponsors3 locations
NCT05691530
Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine
PHASE1Active, not recruiting
127 participants
Started: Mar 7, 2023 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT05688215
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
PHASE1/PHASE2Recruiting
56 participants
Started: Mar 7, 2023 · Completed: Mar 2, 2026
2 conditions2 sponsors1 location
NCT05651594
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
PHASE2Recruiting
40 participants
Started: Mar 7, 2023 · Completed: Mar 30, 2026
11 conditions2 sponsors1 location
NCT05811975
KSX01-TCRT Injection Project in Solid Tumors
EARLY_PHASE1Recruiting
50 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT06128278
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
PHASE2Recruiting
38 participants
Started: Mar 7, 2023 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05633056
An Adaptive Randomized Controlled Trial
NARecruiting
360 participants
Started: Mar 7, 2023 · Completed: Apr 30, 2029
2 conditions3 sponsors1 location
NCT05761782
Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education
N/ARecruiting
1,500 participants
Started: Mar 7, 2023 · Completed: Mar 7, 2025
1 condition1 sponsor1 location
NCT06039241
Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis
N/ARecruiting
900 participants
Started: Mar 7, 2023 · Completed: Mar 8, 2028
1 condition1 sponsor55 locations
NCT05475574
Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit
NARecruiting
954 participants
Started: Mar 7, 2023 · Completed: Sep 21, 2029
1 condition1 sponsor1 location
NCT05744921
A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
PHASE3Recruiting
202 participants
Started: Mar 7, 2023 · Completed: Feb 26, 2029
1 condition1 sponsor37 locations
NCT05758441
Mentoring to be Active for Rural Appalachia Children
NARecruiting
432 participants
Started: Mar 7, 2023 · Completed: Nov 14, 2025
3 conditions1 sponsor1 location
NCT05762276
A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Administered IM in Adult Participants
PHASE1Active, not recruiting
64 participants
Started: Mar 7, 2023 · Completed: Jun 27, 2024
1 condition2 sponsors5 locations
NCT06089096
Sleep Apnea and Cognitive Function in Subjects With Subjective or Mild Cognitive Impairment
N/ARecruiting
250 participants
Started: Mar 7, 2023 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT05770518
Biofeedback vs Laryngeal Control Therapy in Management of Paradoxical Vocal Fold Motion
NAActive, not recruiting
51 participants
Started: Mar 7, 2023 · Completed: Jul 30, 2024
2 conditions1 sponsor1 location
NCT05526924
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
PHASE1Recruiting
30 participants
Started: Mar 7, 2023 · Completed: Jan 1, 2026
5 conditions1 sponsor1 location